GL1X · GenesisL1 explorer

MolNFT v1 · #186062 · protein

The STK17A (DRAK1) kinase domain bound to CK156

7QUF · SERINE/THREONINE-protein kinase 17A: “The STK17A (DRAK1) kinase domain bound to CK156”. X-ray diffraction, 1 ligand (F8I), 5 pockets (best druggability 0.70). MolNFT v1 #186062 on GenesisL1: 3D structure, binding sites and pockets…

PDB
7QUF
Type
protein
Length
519 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase 17A
EC
2.7.11.1
UniProt
Q9UEE5
Ligands
F8I
Pockets
5 · best druggability 0.70

Structure

x-ray diffraction · 2 distinct chains · 39% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase 17A (EC 2.7.11.1)protein27037% helix, 20% strandQ9UEE5
BSERINE/THREONINE-protein kinase 17A (EC 2.7.11.1)protein24941% helix, 14% strandQ9UEE5

Ligands and binding sites

  • F8I · ~{N}-~{tert}-butyl-7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.1^{2,6}.0^{17,20}]docosa-1(20),2(22),3,5,14(21),15,18-heptaene-5-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14530.700.8153F8I
23210.640.8036F8I
34210.610.7642empty
41430.370.7222empty
5970.360.7417empty

Interfaces

1 interface between chains.

  • A–B · 440 Ų buried · 10 hydrogen bonds · protein-protein

Compared structures

  • 7QUF · The STK17A (DRAK1) Kinase Domain Bound to CK156 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9UEE5 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase 17A (Q9UEE5) · a predicted model of the same protein · chain A against A, TM-score 0.90

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.